Whistleblower News: Zantac, Coronavirus Fraud, Medicare Fraud
FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk
NPR
About six months after several major pharmacies pulled Zantac and its generic equivalents off their shelves, citing a potentially harmful contaminant in the heartburn medication, federal regulators are throwing their weight behind the drug's removal from the market. The Food and Drug Administration requested Wednesday that manufacturers immediately pull all prescription and over-the-counter versions of the drug. read more »
$2.2T Coronavirus Relief Package Poses Fraud Threat, Experts Warn
VOICE OF AMERICA
Just days after Congress approved a record $2.2 trillion in emergency economic aid to offset the impact of the coronavirus pandemic, the Trump administration is racing to get the money out to hundreds of millions of Americans and millions of businesses reeling from the crisis.
The mega relief package is being hailed as a desperately needed measure to steady the teetering U.S. economy and to help many of the millions who have lost their jobs. But the sheer size of the aid program and the speed with which it is being doled out threatens to create a perfect storm for fraud and abuse on a magnitude not seen before, according to analysts. read more »
Feds charge Georgia man with orchestrating COVID-19 billing fraud scheme
BECKERS
Federal prosecutors have charged a Georgia man for allegedly conspiring to defraud Medicare and private healthcare benefit programs by submitting fraudulent claims for COVID-19 testing and genetic cancer screenings, according to the Department of Justice.
Erik Santos was arrested March 30 and charged with one count of conspiring to violate the Anti-Kickback Statute and one count of conspiring to commit healthcare fraud. read more »
